Production of p-hydroxycephalexin
AssigneeBristol-Myers Company
InventorsLeonard Bruce Crast, Jr., William Joseph Gottstein
Life of this patent
Estimating the term…
Abstract
Improved yields of 7-[D-.alpha.-amino-.alpha.-(4-hydroxy- and 3-chloro-4-hydroxy-phenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acids are obtained by acylating 7-aminodesacetoxycephalosporanic acid with the mixed anhydride (from ethyl chloroformate) of the ring-substituted 2-phenylglycine when the latter's .alpha.-amino group has been blocked by reaction with a .beta.-keto compound such as methyl acetoacetate. Improved purification processes include the use of dimethylformamide and acetonitrile solvates and solvates and bis-anthraquinone-1,5-disulfonic acid salts.
Claims2
The process of purifying a crude form of 7-(D-.alpha.-amino-4-hydroxyphenylacetamido)-3-cephem-4-carboxylic acid which comprises converting said crude acid to its solid, crystalline dimethylformamide solvate containing 1.5 moles dimethylformamide per mole of said acid, isolating said solid solvate, slurrying it in nearly boiling methanol, preferably at about 50.degree. C., until the solvate dissociates, cooling the suspension and then collecting therefrom substantially pure, solid 7-(D-.alpha.-amino-4hydroxyphenylacetamido)-3-cephem-4-carboxylic acid.
Substantially pure, crystalline dimethylformamide solvate of 7-(D-.alpha.-amino-4-hydroxyphenylacetamido)-3-cephem-4-carboxylic acid containing 1.5 moles dimethylformamide per mole of said acid.
Dependencies are inferred from the claim text.